Discontinued — last reported Q3 '25
Labcorp Holdings Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) decreased by 11.0% to $532.30M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 65.0%, from $1.52B to $532.30M. Over 4 years (FY 2021 to FY 2025), Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) shows a downward trend with a -22.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved liquidity and capacity for investment or debt repayment, while a decrease may indicate aggressive capital allocation or operational cash burn.
This represents the total liquidity available to the company, including cash, cash equivalents, and restricted cash bala...
Consumer staples companies typically maintain moderate cash buffers to manage working capital and dividend obligations.
cash_and_equivalents_total_inclusive| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.47B | $304.90M | $430.00M | $294.80M | $1.93B | $727.90M | $536.80M | $99.30M | $265.10M | $1.52B | $1.52B | $369.40M | $647.30M | $598.10M | $532.30M |
| QoQ Change | — | -79.3% | +41.0% | -31.4% | +554.9% | -62.3% | -26.3% | -81.5% | +167.0% | +472.4% | +0.1% | -75.7% | +75.2% | -7.6% | -11.0% |
| YoY Change | — | — | -70.8% | — | — | +138.7% | +24.8% | -66.3% | -86.3% | +108.4% | +182.9% | +272.0% | +144.2% | -60.6% | -65.0% |